The U.S. Food and Drug Administration has approved the diabetes drug Mounjaro to lower the risk of major cardiovascular events in adults with Type 2 diabetes.
Around 40 million Americans suffer from the chronic health condition that leaves them at an increased risk of heart disease and stroke.